BIOBio-Rad Laboratories, Inc.
$366.40+29% 1Y
$366.40
$241.7152 weeks$390.31
BIO in its own filings
BIO's filing record carries 3 kinds of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
414
Events found in the filings · across 1,510 filings · the record starts in 1994
- Hard flags
- 3
Hard flags
- Most recent filing
- Aug 4, 2026
Most recent filing · Form 10-Q
- Record starts
- May 12, 1994
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Oct 28, 2026
- Change in certifying accountant3 occurrences
- 2013-10-09
- Late periodic report4 occurrences
- 2019-03-04
- Delisting notice / listing-rule failure7 occurrences
- 2019-03-25
- Security removed from listing or deregisteredhistorical · usually a matured note or preferred class, not the common shares
- 2008-10-22
- SEC comment-letter activity23 occurrences
- 2022-12-16
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 4, 2026On July 31, 2026, Bio-Rad Laboratories, Inc. (the “Company ") initiated a strategy-driven restructuring plan as part of our ongoing program to improve operating performance and strengthen the Company’s competitive position.Earnings release · Form 8-K
- Apr 30, 2026Bio-Rad Reports First -Quarter 2026 Financial Results.Earnings release · press release
- Apr 24, 2026On April 21, 2026, at the annual meeting of stockholders (the “Annual Meeting”) of Bio-Rad Laboratories, Inc. (the “Company”), as further described in.Director or officer change · Form 8-K
- Feb 12, 2026Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results.Earnings release · press release
- Oct 29, 2025Bio-Rad Reports Third -Quarter 2025 Financial Results.Earnings release · press release
- Sep 30, 2025Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away.Regulation FD disclosure · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
On our screens:Stocks with no debt
Medical Devices
Ranks #22 of 51 by RyuScore